Related Experiment Video
Updated: Aug 26, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Successful treatment of periostomal pyoderma gangrenosum using topical tacrolimus
The British Journal of Dermatology
|March 5, 2004
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Pharmacogenetic biomarkers for secukinumab response in psoriasis patients in real-life clinical practice.
Journal of the European Academy of Dermatology and Venereology : JEADV·2023
Dermatologists' Role in the Early Diagnosis of Psoriatic Arthritis: Expert Recommendations.
Actas dermo-sifiliograficas·2020
Paper Mills in Dermatology: A Cross-Sectional Study of Retracted Publications.
The British journal of dermatology·2026
Distinct genotype-phenotype patterns in non-syndromic hereditary hypotrichosis: a multicenter Chinese cohort.
The British journal of dermatology·2026
Efficacy and Safety of Recibokibart, an Interleukin-36 Receptor Antibody, in Generalized Pustular Psoriasis: A Phase 2 Randomized Trial.
The British journal of dermatology·2026
Inhaled corticosteroids with short-acting β2-agonists as rescue therapy for asthma: a systematic review and meta-analysis of randomized controlled trials.
The Journal of asthma : official journal of the Association for the Care of Asthma·2026
Age- and Phenotype-Specific Patterns of Atopic and Autoimmune Comorbidities in Alopecia Areata: A Cross-Sectional Study.
Journal of cutaneous medicine and surgery·2026
Real-world clinical experience with ruxolitinib cream versus systemic therapies in patients with moderate atopic dermatitis in the United States.
The Journal of dermatological treatment·2026
Inflammation and Immune Dysregulation Across Respiratory Diseases: From Cellular Mechanisms to Therapeutic Targets.
Journal of inflammation research·2026
Real-World Efficacy and Systemic Immune Modulation Upon Tralokinumab Treatment in Atopic Dermatitis.
Clinical and translational allergy·2026